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In the last two decades, many studies have focused on whether periodontitis is a 
risk factor for preterm birth (PTB). However, both epidemiological investigation and 
intervention trials have reached contradictory results from different studies. What 
explains the different findings, and how should future studies be conducted to better 
assess this risk factor? This article reviews recent epidemiological, animal, and in vitro 
studies as well as intervention trials that evaluate the link between periodontitis and 
PTB. Periodontitis may act as a distant reservoir of microbes and inflammatory 
mediators and contribute to the induction of PTB. Animal studies revealed that maternal 
infections with periodontal pathogens increase levels of circulating IL-1β, IL-6, IL-8, 
IL-17, and TNF-α and induce PTB. In vitro models showed that periodontal pathogens/
byproducts induce COX-2, IL-8, IFN-γ, and TNF-α secretion and/or apoptosis in 
placental tissues/cells. The effectiveness of periodontal treatment to prevent PTB is 
influenced by the diagnostic criteria of periodontitis, microbial community composition, 
severity of periodontitis, treatment strategy, treatment efficiency, and the period of 
treatment during pregnancy. Although intervention trials reported contradictory results, 
oral health maintenance is an important part of preventive care that is both effective 
and safe throughout pregnancy and should be supported before and during pregnancy. 
As contradictory epidemiological and intervention studies continue to be published, 
two new ideas are proposed here: (1) severe and/or generalized periodontitis promotes 
PTB and (2) periodontitis only promotes PTB for pregnant women who are young or 
HIV-infected or have preeclampsia, pre-pregnancy obesity, or susceptible genotypes.
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iNTRODUCTiON
Each year, about 15 million infants worldwide are born preterm (before 37 weeks of gestation), and 
these preterm babies typically have low birth weight (LBW, <2,500 g) (1). Preterm birth (PTB) is the 
leading cause of neonatal mortality, morbidity, and developmental loss (2). Advances in obstetric 
care have not altered the rates of PTB, and it is estimated that 9.6% of worldwide births are preterm 
(3). The highest rates of PTB are in Africa (11.9%) and North America (10.6%), and the lowest 
rates are in Europe (6.2%) (3). However, the underlying causes of PTB are still not entirely clear, 
thus an accurate identification of risk factors for PTB that are amenable to intervention would have 
far-reaching and long-lasting impact.
Of the multiple risk factors for PTB, maternal infection is identified consistently. Periodontal 
disease is a highly prevalent infectious and inflammatory disease of tooth-supporting tissues and 
if untreated can lead to oral disabilities (Figure  1A) (4). Periodontal disease is caused mainly 
FigURe 1 | Periodontal disease is a highly prevalent infectious and inflammatory disease of tooth-supporting tissues. (A) The arrowheads indicate 
periodontal disease. (B) Periodontal disease includes gingivitis and periodontitis. Gingivitis is the presence of gingival inflammation without loss of connective tissue 
attachment. Periodontitis is the presence of gingival inflammation at sites where there has been apical migration of the epithelial attachment onto the root surfaces 
accompanied by the loss of connective tissue and alveolar bone. (C) Clinical attachment loss is measured with a periodontal probe and is the distance from the 
base of the probeable crevice to the cementoenamel junction. Probing depth is defined as the distance between the bottom of the periodontal pocket and the 
gingival margin.
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by gram-negative microaerophilic and anaerobic bacteria that 
colonize the subgingival area and produce significant amounts 
of proinflammatory mediators (5). Periodontal disease includes 
gingivitis and periodontitis. Gingivitis is the presence of gingival 
inflammation without loss of connective tissue attachment. 
Periodontitis is the presence of gingival inflammation at 
sites where there has been apical migration of the epithelial 
attachment onto the root surfaces accompanied by the loss of 
connective tissue and alveolar bone (Figure  1B) (6). In the 
last two decades, many studies have examined the relationship 
between periodontitis and PTB. Periodontitis may be a risk 
factor for PTB due to the presence in the bloodstream of 
bacteria and proinflammatory cytokines during infection that 
can affect distant organs (7). However, epidemiological studies 
and intervention trials have reached contradictory conclusions 
about the relationship between periodontitis and PTB. The 
aim of this review is to summarize the current evidence from 
epidemiological, animal, and in vitro studies, as well as interven-
tion trials and to propose new ideas about the link between 
periodontitis and PTB.
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ePiDeMiOLOgiCAL ReSULTS
About one-third of all PTB are caused by preterm labor (uterine 
contraction) and one-third are due to the premature rupture of 
membranes (PROM); the remaining cases are due to other preg-
nancy complications such as induced labor (of which preeclamp-
sia is the major indication) (8). In the last two decades, numerous 
epidemiological studies have examined the link between peri-
odontitis and PTB, including cross-sectional, case–control, and 
cohort studies.
In a cross-sectional study, or census, data are collected at 
a defined time and is used to assess the prevalence of chronic 
or acute conditions, the results of intervention, or the causes 
of disease. In the last 5  years, several cross-sectional studies 
(9–11) reported a correlation between periodontitis and PTB/
LBW. In a study published in 2016 (9), women with PTB were 
found to have worse periodontal parameters and significantly 
increased gingival crevicular fluid (GCF) levels of IL-6 and 
prostaglandin E2 (PGE2) compared with women who experi-
enced full-term birth. Based on significant correlations between 
serum PGE2 level and probing depth, clinical attachment loss 
(CAL, Figure  1C), and GCF TNF-α in PTB, periodontitis 
may increase the risk of labor triggers and hence contribute 
to preterm labor onset. However, in 2016 Martinez-Martinez 
et al. (12) suggested that PTB is a multifactorial condition and 
that periodontitis and the presence of periodontal pathogens 
are not sufficient to trigger PTB.
In case–control studies, mothers with PTB are identified and 
their periodontitis history is determined and compared with 
that of healthy control subjects. Of the 14 case–control studies 
published in the last 5 years, 12 (13–24) reported an association 
between periodontitis and PTB, LBW, or preterm LBW (PLBW), 
and 2 (25, 26) found no association. In a study published in 2015 
(23), mothers in the periodontitis group with single delivery had 
an eightfold higher chance of delivering a LBW infant compared 
to those in the control group. The mothers in the periodontitis 
group with multiple deliveries delivered PTB infants with an 
eightfold higher frequency and LBW infants at a 10-fold higher 
frequency compared to the mothers in the control group.
In cohort studies, investigators monitor pregnant women 
to determine if those with periodontitis demonstrate a higher 
incidence of PTB than those without periodontitis. Of the 11 
published cohort studies in the last 5 years, 7 (27–33) reported 
an association between periodontitis and PTB, LBW, or PLBW, 
and 4 (34–37) revealed no association. A hospital-based pro-
spective study published in 2016 (33) comprising 790 pregnant 
women found that periodontitis was a risk factor for PTB and an 
independent risk factor for LBW. Recently periodontitis was also 
found to be associated with preeclampsia (38) and PROM (39, 
40), common causes of PTB.
In the last 5  years, most literature and systematic reviews 
reported an association between periodontitis and PTB (41–46). 
A meta-analysis published in 2016 (41) assessed case–control 
studies reporting periodontal status and pregnancy outcomes. 
The computed risk ratio for periodontitis was 1.61 for PTB 
using data from 16 studies, the risk for LBW was 1.65 based on 
10 studies, and the risk for PLBW was 3.44 based on 4 studies. 
A systematic and evidence-based review in 2012 (46) focused on 
the association of periodontitis and PTB and LBW and found 
62 relevant studies that suggested that periodontitis may be a 
potential risk factor for PTB and LBW.
Different epidemiological data may have reached different 
conclusions due to the following reasons: (1) many studies used 
different definitions of periodontitis and adverse pregnancy 
outcomes, for instance the use of PLBW as a composite outcome, 
or PTB versus LBW, terms that reflect different disease severities 
and pathologic entities. (2) The risk factors of PTB may be similar 
to the risk factors for periodontitis (ethnicity, tobacco use, and 
socioeconomic and educational levels) and thus may confound 
the association between periodontitis and PTB. In a prospective 
case–control study (47), PTB was associated with periodontitis 
when the USA (48), but not the European (49), definitions were 
used. Therefore, future studies should employ both continuous 
and categorical assessment of periodontal status and control for 
confounding factors. Additionally, the further use of the compos-
ite outcome PLBW is not encouraged.
BiOLOgiCAL HYPOTHeSeS
Periodontitis is one of the most common chronic infectious 
diseases and is caused mainly by gram-negative microaerophilic 
and anaerobic bacteria that colonize the subgingival area and 
produce significant amounts of proinflammatory mediators, 
mainly IL-1β, IL-6, PGE2, and TNF-α (4). Periodontitis may act as 
a distant reservoir of both microbes and inflammatory mediators 
that may influence pregnancy and contribute to induction of PTB 
(Figure 2). These two potential mechanisms for how periodonti-
tis can affect PTB are described more fully below.
Bacterial Spreading
Periodontal microorganisms can act as pathogens not only in 
the oral cavity but also in other body areas. This is due to the 
following characteristics of bacteria: (1) the ability to rapidly 
colonize, (2) the ability to elude the host’s defense mecha-
nisms, and (3) the ability to produce substances that directly 
contribute to the destruction of tissue. Periodontal pathogens/
byproducts may reach the placenta and enter the amniotic fluid 
and fetal circulation, serving to activate inflammatory signaling 
pathways.
Porphyromonas gingivalis has been detected in human 
placenta tissues (50). Interestingly, one study reported that P. gin-
givalis was only detected within the villous mesenchyme in the 
preterm cohort, but not the term group (51). Thus, the detection 
of P. gingivalis in the placenta may be related to PTB (52, 53).
The Fusobacterium nucleatum subsp. polymorphum strain was 
not detected in vaginal samples, but was found in both neonatal 
gastric aspirates and oral samples from mothers with PTB and 
localized periodontal pockets, which strongly indicated that F. 
nucleatum subsp. polymorphum of oral origin may relate to PTB 
(54). Bohrer et al. (55) reported a case of acute chorioamnionitis 
caused by F. nucleatum that progressed to maternal sepsis in a 
term patient with intact membranes. Cassini et al. (56) reported 
that the presence of periodontal pathogen Treponema denticola in 
the vagina, regardless of the levels, increased risk of PTB.
FigURe 2 | Potential biological mechanisms linking periodontal disease to preterm birth. In periodontitis, gingival ulceration in the periodontal pocket 
enables egress and systemic bacterial dissemination, and locally produced proinflammatory cytokines can enter systemic circulation and induce an acute-phase 
response in the liver that is characterized by an increased level of C-reactive protein.
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Levels of P. gingivalis, F. nucleatum, Actinomyces actinomycet-
emcomitans, Tannerella forsythia, T. denticola, Eikenella corrodens, 
and Capnocytophaga spp. have been reported at significantly 
higher levels in preterm deliveries as compared to term births 
(37, 52, 57). In one study (58), when Prevotella intermedia and/
or Aggregatibacter actinomycetemcomitans were not detected in 
maternal periodontal pockets, the infants were more than 129% 
likely to have a normal birth weight.
The above findings suggest that periodontal bacteria may be 
normally present in the placenta. However, the levels of certain 
periodontal pathogens in the placenta may be dependent on 
the maternal periodontal state (59). Further studies are needed 
to elucidate the role of microbial load and maternal immune 
responses in PTB.
Hematogenous Dissemination of 
inflammatory Products
Clinical attachment loss, as the main periodontal measure, is 
associated with plasma levels of IL-1β and TNF-α in pregnant 
women (60), which may promote labor activation through pla-
cental and chorion–amnion production of PGE2 (61). Women 
with PTB demonstrated significantly increased GCF levels of 
IL-6 and PGE2 compared with those who had full-term births 
(9). A systematic review in 2013 (62) reported an association 
between GCF inflammatory mediator levels and adverse 
pregnancy outcomes. In a subset of patients with severe peri-
odontitis, locally produced proinflammatory mediators—such 
as IL-1β, IL-6, and TNF-α—can enter systemic circulation and 
induce an acute-phase response in the liver that is character-
ized by an increased level of C-reactive protein (CRP) (63, 64). 
Serum CRP level was reported to be elevated in subjects with 
periodontitis (65). An increased CRP level can enhance the 
risk of cardiovascular disease, cerebrovascular accidents, and 
PLBW infants (65).
Clinical studies support the association between increased 
levels of circulating proinflammatory mediators and PTB (66, 
67) and have implicated IL-1β and IL-6 as major players in the 
onset of PTB (68, 69). Moreover, polymorphisms in proinflam-
matory genes, including the above-mentioned cytokines, have 
been associated with PTB (70, 71). In addition, elevated amni-
otic fluid level of IL-6 in the second trimester was associated 
with the initiation and timing of PTB (72, 73). Therefore, the 
potential link between periodontitis and PTB may be explained 
by the following mechanisms. First, periodontal pathogens/
byproducts can disseminate toward the placental and fetal 
tissues. Immune/inflammatory reactions within the placental 
tissues of the pregnant woman may occur, and the release of 
proinflammatory mediators in the amniotic fluid may increase 
and further contribute to PTB. Second, systemic inflammatory 
changes induced by periodontitis can exacerbate local inflam-
matory responses within the fetoplacental unit to increase the 
risk for PTB.
eXPeRiMeNTAL ANiMAL MODeLS
The possible roles of periodontitis in PTB have also been explored 
using experimental animal models. In separate studies, peri-
odontal bacteria were injected into a small chamber in pregnant 
animals, allowing the establishment of a site of infection distant 
to the fetal–placental unit to mimic a periodontal infection in 
a reproducible and simplified manner. These results revealed 
that maternal infections with periodontal pathogens increase 
pregnancy complications.
Dental infection of mice with P. gingivalis significantly 
increased levels of circulating IL-1β, IL-6, IL-17, and TNF-α 
(74). Defects in the placental tissues of P. gingivalis-infected 
mice included degenerative changes in endothelial and 
trophoblast cells, increased placental detachment, and PROM, 
and P. gingivalis was detected in placental tissues by PCR and 
immunohistochemistry (74). The P. gingivalis-infected group 
delivered at gestational day (gd) 18.25 versus gd 20.45 for the 
non-infected control group (p <  0.01), with pups exhibiting 
LBW compared to controls (p <  0.01) (74). In another study 
(75), mice with periodontitis induced by using an inoculum of 
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P. gingivalis and F. nucleatum exhibited increased circulating 
levels of IL-6 and IL-8. Similarly, Miyoshi et al. (76) found high 
levels of contractile-associated proteins and ion channels in the 
myometrium of PTB model mice with chronic odontogenic P. 
gingivalis infection. In murine models, F. nucleatum translocated 
and caused intrauterine infections (77) and Campylobacter rec-
tus significantly decreased fetoplacental weight (78). In a baboon 
model, a significantly greater frequency of the periodontitis 
group neonates had decreased gestational age and LBW (79). 
Spontaneous abortion/stillbirth/fetal demise was increased in 
the periodontitis group versus the control group (79). Also, 
combined oral infection of mice with P. gingivalis and C. rectus 
significantly reduced overall fecundity compared to controls 
(80). Overall, most animal studies reported a harmful impact 
of periodontitis on pregnancy outcome. However, a study per-
formed by Fogacci et al. (81) found no increased risk for PTB or 
LBW in Wistar rats with induced periodontitis.
IN VITRO MODeLS
In addition to the data from animal studies, in vitro experiments 
have been conducted to explore the molecular mechanisms 
underlying periodontitis-induced PTB. In most in vitro models, 
periodontal pathogens/byproducts were used to infect placental 
tissues or trophoblast cells/cell lines. These experiments were 
designed to mimic an in  vitro periodontal infection in a 
simplified and reproducible manner to allow investigation of 
the interaction between periodontal pathogens and placental 
tissues/cells.
Riewe et al. (82) investigated the transcriptional responses after 
infection with P. gingivalis in extravillous trophoblast (HTR8) 
cells derived from the human placenta, and found that over 2,000 
genes were differentially regulated. P. gingivalis induced IL-8 and 
IFN-γ secretion (83), apoptosis, and arrest in the G(1) phase of 
the cell cycle (84, 85) in HTR8 cells. Increased IFN-γ secretion 
and Fas expression occurred in P. gingivalis-induced apoptosis of 
HTR8 cells via the ERK1/2 pathway (86). In normal human term 
fetal membrane explants, P. gingivalis may significantly increase 
TLR7 expression (87).
Porphyromonas gingivalis has bioactive components on 
the cell surface, including lipopolysaccharide, capsules, and 
fimbriae. P. gingivalis lipopolysaccharide induces the produc-
tion of IL-6 and IL-8 via TLR2 in chorion-derived cells (50) 
and increases expression levels of IL-8, TNF-α, and COX-2 in 
HTR8 cells in an NF-κB-dependent manner (74). Interestingly, 
Komine-Aizawa et al. (88) reported that although there is lim-
ited direct pathogenic effect of P. gingivalis lipopolysaccharide 
on trophoblast invasion, concurrent smoking reduces tropho-
blast invasion into the myometrium and thus inhibits maternal 
vascular reconstruction.
In human placental trophoblast-like BeWo cells, the presence 
of A. actinomycetemcomitans lipopolysaccharide led to increased 
levels of cytochrome c, caspase-2, caspase-3, caspase-9, and 
BCL2-antagonist/killer 1 mRNA and decreased levels of B-cell 
CLL/lymphoma 2, BCL2-like 1, and catalase mRNA, consistent 
with the activation of the mitochondria-dependent apoptotic 
pathway (89). Additionally, C. rectus was reported to effectively 
invade BeWo cells and upregulate both mRNA and protein levels 
of IL-6 and TNF-α in a dose-dependent manner (78). Therefore, 
there is significant evidence that periodontal pathogens and 
byproducts can induce inflammation and/or apoptosis in placen-
tal tissues and cells.
eFFeCT OF PeRiODONTAL TReATMeNT 
ON PTB iNCiDeNCe
Periodontal treatment usually refers to non-surgical periodontal 
therapy that can improve periodontal health and is defined as 
plaque removal, plaque control, supragingival and subgingival 
scaling, root surface debridement, and the adjunctive use of 
chemical agents. To evaluate periodontitis as a risk factor for 
PTB, intervention studies were conducted to evaluate the effect 
of periodontal treatment on the risk of PTB. In these studies, 
women with preexisting periodontitis were randomly divided 
into two groups. One received periodontal treatment during or 
before pregnancy, and the other did not. In this type of study, the 
researchers could assess if periodontitis was an independent risk 
factor for PTB by determining if periodontal treatment decreased 
the incidence of PTB.
In a study published in 2015 (90), the mean gestational age 
in the periodontal treatment group (treatment performed during 
the second trimester of the gestational period) was 35.57 ± 2.40 
versus 34.17 ± 2.92 weeks in the non-treated group (p < 0.05). 
The treatment group showed a statistically significant reduction 
in mean CRP levels after delivery compared to baseline values; 
the control group showed no significant reduction in CRP levels. 
Another study (91) suggested that periodontal treatment during 
pregnancy is not only safe for both the child and the mother, but 
also provides beneficial effects for pregnancy and embryo-fetal 
development, leading to reduced morbidity and mortality in PTB 
infants. Macedo et al. (92) also reported an association between 
a low number of daily tooth brushings and PTB. However, in 
other recent studies (93–96), periodontal treatment performed 
on pregnant women was not found to be efficacious in reducing 
PTB or LBW.
Data from recent systematic reviews are also contradictory. 
Several reviews (97–99) reported that the risks of perinatal 
outcomes could be potentially reduced by periodontal treatment 
in pregnant women, but other reviews (100–103) suggested that 
periodontal treatment during pregnancy was not an efficient 
way to reduce the incidence of PTB. However, the evidence was 
not conclusive due to confounding effects and risks of random 
errors and bias. Thus, further randomized clinical trials are still 
necessary.
The preventive effectiveness of periodontal treatment for PTB 
has still not been established, because it is influenced by many 
factors such as the diagnostic criteria of periodontitis, microbial 
community composition, severity of disease, treatment strategy, 
treatment efficiency, and the timing of treatment during preg-
nancy (the pre-pregnancy period or during the first or second 
trimester). Jeffcoat et  al. (104) confirmed that decreased PTB 
may depend on the success of periodontal treatment. In this 
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study of 322 pregnant women with periodontitis, 162 were 
randomly assigned to receive only oral hygiene instruction and 
served as the untreated control group, whereas the remaining 
160 received scaling and root planing treatment as well as 
oral hygiene instruction. No significant difference was found 
between the incidence of PTB in the periodontal treatment 
group and the control group. However, a logistic regression 
analysis showed a significant and strong relationship between 
successful periodontal treatment and full-term birth. Subjects 
refractory to periodontal treatment were significantly more 
likely to have PTB. Similarly, in another study (105), periodontal 
treatment during pregnancy reduced the levels of IL-1β, IL-6, 
IL-10, and IL-12 in GCF and improved dental parameters. 
Additionally, the severity of periodontitis was significantly 
associated with an increased risk of babies born small for 
gestational age, but no changes in pregnancy-related outcomes 
were observed following periodontal treatment. These studies 
suggest the need for the next randomized controlled trials to 
standardize methodological criteria and utilize a more precise 
definition of periodontitis. Additionally, for better statistical 
power, studies should preferably be performed as multicenter 
studies, and include a large number of participants. Finally, 
the resulting success or failure of periodontal treatment must 
be considered.
Preterm birth is the leading cause of infant morbidity and 
mortality, but classical risk factors explain only one-third of 
PTB cases, and current intervention strategies have not led to 
an appreciable reduction of PTB. Therefore, it is necessary to 
explore mechanisms of causality and generate new hypotheses 
using an integrated approach. This should be done with increased 
collaboration among research groups, and using more compre-
hensive theoretical–methodological approaches to formulate 
more effective intervention strategies and to detect new risk 
factors. Although intervention during pregnancy has not consist-
ently been correlated with a reduction in PTB rates, oral health 
maintenance is an important part of preventive care that is both 
effective and safe throughout pregnancy and should be supported 
before and during pregnancy.
TwO New iDeAS ABOUT THe ROLe 
OF PeRiODONTiTiS iN PTB
Severe and/or generalized Periodontitis 
Promotes PTB
The severity of periodontitis can be categorized based on CAL 
as follows: mild = 1–2 mm, moderate = 3–4 mm, and severe 
≥5 mm (106). CAL is measured with a periodontal probe and 
is the distance from the base of the probeable crevice to the 
cementoenamel junction (107). In a case–control study (92), 
periodontitis that met definition 1 (four or more teeth with 
at least one site showing CAL of ≥3  mm and probing depth 
of ≥4 mm) was not associated with fewer weeks of gestation. 
However, a significant association was found between PTB 
and periodontitis that was classified according to definition 
2 (four or more teeth with at least one site showing CAL of 
≥4 mm and probing depth of ≥4 mm). A cohort study (108) 
of preeclamptic women showed that 49.3% of patients with 
mild periodontitis and 82.6% of patients with moderate to 
severe periodontitis delivered preterm. Several studies (47, 
109–111) found a highly significant association between PTB 
and moderate to severe periodontitis. Other studies (112, 113) 
also suggested that the strength of the association between 
periodontitis and PTB incidence is higher with increased 
severity of periodontitis.
Periodontitis can also be defined according to the extent of the 
disease. Generalized periodontitis is defined as CAL ≥3 mm and 
probing depth ≥4 mm on four or more teeth and localized peri-
odontitis is defined as CAL ≥3 mm and probing depth ≥4 mm on 
two or three teeth (6). In a case–control multi-center study (114) 
of singleton live births, periodontal examinations after delivery 
identified generalized and localized periodontitis. Generalized 
periodontitis was identified in 13.4% of PTB women and in 10.8% 
of control women, and localized periodontitis was identified in 
11.6 and 10.8%, respectively (114). A significant association was 
observed between generalized periodontitis and PTB (114). A 
case–control study (115) confirmed that only the presence of 
gingival recession for more than two teeth increased the risk of 
PTB. In addition, several studies (108, 111, 116) reported greater 
risk for PTB for mothers if periodontitis progressed during 
pregnancy.
Periodontitis Only Promotes PTB for 
Pregnant women who Are Young or  
Hiv-infected or Have Preeclampsia,  
Pre-Pregnancy Obesity, or Susceptible 
genotypes
Usin et al. (58) reported that the presence of periodontal patho-
gens in periodontal pockets from pregnant women with different 
periodontal status was only associated with PLBW infants for 
young mothers. Pattrapornnan et al. (117) also found a positive 
risk of PTB, LBW, and PLBW in HIV-infected pregnant women 
with periodontitis. Nabet et al. (114) demonstrated a significant 
association between periodontitis and PTB for preeclampsia. 
Riche et  al. (108) and Pattanashetti et  al. (118) confirmed that 
pregnant women with preeclampsia exhibited a greater risk for 
PTB if periodontitis was present or progressed during pregnancy. 
Interestingly, Lee et al. (119) reported that pregnant women with 
periodontitis were 5.56 times more likely to have PTB with preec-
lampsia than women without periodontitis and that the associa-
tion was much stronger (odds ratio 15.94) in women with both 
periodontitis and obesity. In fact, there is a strong association 
between pre-pregnancy obesity and periodontitis in pregnant 
females (120).
Genetic factors involved in altered immune response against 
bacterial infections may also influence the effect of periodontitis 
in pregnancy. Periodontitis induced by P. gingivalis was found 
to drive periodontal microbiota dysbiosis and cause systemic 
disease via an impaired adaptive immune response in mice 
(121). Jeffcoat et al. (122) reported a significant relation between 
a specific polymorphism of prostaglandin E receptor 3 (a gene 
associated with inflammatory response) and both periodontitis 
treatment failure and spontaneous PTB.
7Ren and Du Periodontitis and Preterm Birth
Frontiers in Immunology | www.frontiersin.org February 2017 | Volume 8 | Article 139
CONCLUSiON
Here, for the first time, we describe four possible models of peri-
odontitis in PTB: (1) periodontitis is an independent risk factor for 
PTB; (2) severe and/or generalized periodontitis promotes PTB; 
(3) periodontitis only promotes PTB for pregnant women who 
are young or HIV-infected or have preeclampsia, pre-pregnancy 
obesity, or susceptible genotypes; and (4) periodontitis has no 
significant effect on PTB. Because contradictory epidemiological 
data continue to emerge (model 1 versus 4), future studies should 
try to test the second and third models, which may, to some 
extent, explain the conflicting epidemiological data. Although 
intervention during pregnancy has not consistently been cor-
related with a reduction in PTB rates, oral health maintenance 
is an important part of preventive care that is both effective and 
safe throughout pregnancy and should be supported before and 
during pregnancy.
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